Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 12
Submit an article Journal homepage
1,028
Views
6
CrossRef citations to date
0
Altmetric
Letter

A hemodialysis patient with higher-risk myelodysplastic syndrome treated with standard-dose azacitidine

Johanna C. HamDepartment of Hematology, Isala Clinics, Zwolle, The NetherlandsCorrespondence[email protected]
,
Judith M. Hoogendijk-van den AkkerDepartment of Nephrology, Isala Clinics, Zwolle, The Netherlands
&
Leo F. VerdonckDepartment of Hematology, Isala Clinics, Zwolle, The Netherlands
Pages 2521-2522 | Received 18 Feb 2012, Accepted 19 Apr 2012, Published online: 21 May 2012

References

  • Fenaux P, Mufti GJ, Hellström-Lindberg E, . Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009;10:223–232.
  • Fenaux P, Mufti GJ, Hellström-Lindberg E, . Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukaemia. J Clin Oncol 2010;28:562–569.
  • Azacitidine prescribing information. Celgene Corp., Summit, NJ, August 2011.
  • Fenaux P, Bowen D, Gattermann N, . Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion. Leuk Res 2010;34:1410–1416.
  • Batty GN, Kantarjian H, Issa JP, . Feasibility of therapy with hypomethylating agents in patients with renal insufficiency. Clin Lymphoma Myeloma Leuk 2010;10:205–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.